AI assistant
Sending…
AEHR TEST SYSTEMS — Director's Dealing 2013
Jul 24, 2013
32300_dirs_2013-07-24_8cc9ab70-6c6d-4bcb-b692-5f429f1ad5a4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AEHR TEST SYSTEMS (AEHR)
CIK: 0001040470
Period of Report: 2013-07-24
Reporting Person: ANDERSON ROBERT R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-07-24 | Common Stock | M | 6252 | $0.75 | Acquired | 180924 | Direct |
| 2013-07-24 | Common Stock | M | 30000 | $0.8 | Acquired | 210924 | Direct |
| 2013-07-24 | Common Stock | M | 3334 | $0.89 | Acquired | 214258 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-07-24 | Non-Qualified Stock Option (right to buy) | $0.75 | M | 6252 | Disposed | 2019-01-31 | Common Stock (6252) | Direct |
| 2013-07-24 | Non-Qualified Stock Option (right to buy) | $0.8 | M | 30000 | Disposed | 2019-11-28 | Common Stock (30000) | Direct |
| 2013-07-24 | Non-Qualified Stock Option (right to buy) | $0.89 | M | 3334 | Disposed | 2018-10-25 | Common Stock (3334) | Direct |
Footnotes
F1: One sixth (1/6) of the total number of shares became exercisable on this date and an additional one sixth (1/6) of the total number of shares became exercisable each month thereafter.
F2: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter.
More from AEHR TEST SYSTEMS
Capital/Financing Update
2026
Apr 20
Capital/Financing Update
2026
Apr 8
Earnings Release
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Major Shareholding Notification
2026
Feb 9
Director's Dealing
2026
Feb 4